ACF may revolutionize the approach not only inthe field of radiotherapyor chemotherapy but also in cancer immunotherapy.110 The therapeutic benefits of ACF in combination therapywith TRP-2 and anti-PD-1 antibodies have been reported in the treatmentof melanoma. Here, PDCD1 is linked to cancer.